These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17376993)

  • 21. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
    Gao HM; Liu B; Zhang W; Hong JS
    FASEB J; 2003 Oct; 17(13):1954-6. PubMed ID: 12897068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice.
    Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
    PLoS One; 2016; 11(3):e0151569. PubMed ID: 26982707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
    Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
    Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
    Breidert T; Callebert J; Heneka MT; Landreth G; Launay JM; Hirsch EC
    J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.
    Gao HM; Jiang J; Wilson B; Zhang W; Hong JS; Liu B
    J Neurochem; 2002 Jun; 81(6):1285-97. PubMed ID: 12068076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
    Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease.
    Main BS; Zhang M; Brody KM; Ayton S; Frugier T; Steer D; Finkelstein D; Crack PJ; Taylor JM
    Glia; 2016 Sep; 64(9):1590-604. PubMed ID: 27404846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
    J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson's disease mouse model.
    Liu WW; Wei SZ; Huang GD; Liu LB; Gu C; Shen Y; Wang XH; Xia ST; Xie AM; Hu LF; Wang F; Liu CF
    FASEB J; 2020 May; 34(5):6570-6581. PubMed ID: 32246801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.
    Berman AE; Chan WY; Brennan AM; Reyes RC; Adler BL; Suh SW; Kauppinen TM; Edling Y; Swanson RA
    Ann Neurol; 2011 Mar; 69(3):509-20. PubMed ID: 21446024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
    Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
    Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats.
    Lu X; Bing G; Hagg T
    Neuroscience; 2000; 97(2):285-91. PubMed ID: 10799760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease.
    Qiao C; Dang T; Zhou Y; Zhou YZ; Zhao R; Wang M
    Brain Behav; 2022 Nov; 12(11):e2784. PubMed ID: 36199191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.